📢 Gate Square Exclusive: #PUBLIC Creative Contest# Is Now Live!
Join Gate Launchpool Round 297 — PublicAI (PUBLIC) and share your post on Gate Square for a chance to win from a 4,000 $PUBLIC prize pool
🎨 Event Period
Aug 18, 2025, 10:00 – Aug 22, 2025, 16:00 (UTC)
📌 How to Participate
Post original content on Gate Square related to PublicAI (PUBLIC) or the ongoing Launchpool event
Content must be at least 100 words (analysis, tutorials, creative graphics, reviews, etc.)
Add hashtag: #PUBLIC Creative Contest#
Include screenshots of your Launchpool participation (e.g., staking record, reward
Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity company, regularly receiving stem cell intravenous infusion therapy over the past year.
On August 21, Bloomberg reported that CEX co-founder Arthur Hayes is shifting his investment focus toward the field of human lifespan extension. He has recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok and has joined its board of directors. Over the past year, he has regularly traveled to receive intravenous infusion therapy, stating that "I hope to extend my lifespan as healthily as possible." Although the company name has not been disclosed due to a rebranding, he emphasized: "This is the trend of the future — more and more countries are relaxing regulations on the use of stem cells."